{
  "ptid_time": "099_S_6038_2020-01-16",
  "img_path": "/data/qiuhui/data/adni/images/099_S_6038/2020-01-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 40,573 mm³, 5.3% above the reference mean. With a Z-score of 0.13 (55.1th percentile), this represents normal volume ; hippocampal volume measures 6,181 mm³, 18.2% below the reference mean. With a Z-score of -1.78 (3.8th percentile), this represents moderate atrophy; whole brain volume measures 942,251 mm³, 12.7% below the reference mean. With a Z-score of -1.65 (5.0th percentile), this represents moderate atrophy; entorhinal cortex volume measures 4,800 mm³, 17.1% above the reference mean. With a Z-score of 1.16 (87.6th percentile), this represents mild enlargement; fusiform gyrus volume measures 16,397 mm³, 13.0% below the reference mean. With a Z-score of -1.10 (13.5th percentile), this represents mild atrophy; middle temporal gyrus volume measures 18,324 mm³, 14.1% below the reference mean. With a Z-score of -1.27 (10.2th percentile), this represents mild atrophy. ",
  "text_data": "Age is 79.4 years. Gender is Male. Education: 16 years. MMSE: 29.0. MoCA: 20.0. Logical Memory: 13.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.98 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate atrophy in the hippocampus and whole brain, along with mild atrophy in the fusiform gyrus and middle temporal gyrus—regions commonly affected in Alzheimer's disease. Despite a normal MMSE (29/30), the MoCA score (20/30) suggests mild cognitive impairment, and the absence of amyloid pathology (AV45 normal) makes typical AD less likely, possibly pointing toward non-AD neurodegeneration (e.g., hippocampal sclerosis or primary age-related tauopathy).  \n\n**Diagnosis:** **MCI** (given cognitive decline on MoCA but preserved independence in daily activities). If further history reveals functional impairment, progression to **dementia** (likely non-AD etiology) would be considered.  \n\n**Confidence:** **Medium** (atypical profile with normal amyloid but significant atrophy; clinical correlation needed).  \n\n*Note:* APOE4-negative status and normal AV45 reduce likelihood of AD, but hippocampal atrophy + MoCA decline still imply neurodegeneration. Follow-up with tau PET or CSF biomarkers could clarify.",
  "timestamp": "2025-07-26T11:11:57.707386"
}